Profile
| Metric | Value |
|---|---|
| Full Name | Rapport Therapeutics, Inc. |
| Ticker | NASDAQ: RAPP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | - |
| Indexes | Not included |
| Website | rapportrx.com |
| Employees | 69 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $30.12 | |
| Price, 1D Change | +8.89% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.07 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$2.14 | |
| EPS, 1Y Change | -125.10% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.14 | |
| EPS Estimate | -$2.83 | |
| EPS Est. Change | -32.28% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $30.12 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +66.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$13.97 | -$2.14 | +84.68% | |
| -$2.83 | N/A | -32.28% | |
| -$3.44 | N/A | -60.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +69.36% | |
| Price, 3Y | - | |
| Market Cap, 1Y | +68.98% | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -125.10% | |
| EPS, 3Y | -635.13% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $30.12 | |
| SMA 200 | $18.72 | |
| SMA 200 vs Price | -37.85% | |
| SMA 50 | $28.15 | |
| SMA 50 vs Price | -6.54% | |
| Beta | 1.07 | |
| ATR | $1.95 | |
| 14-Day RSI | 54.13 | |
| 10-Day Volatility | 67.04% | |
| 1-Year Volatility | 156.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$2.14 | |
| Gross Profit | -$839.00K | |
| - | ||
| Operating Profit | -$83.06M | |
| - | ||
| Net Income | -$78.31M | |
| - | ||
| EBITDA | -$82.22M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| 35.34 | ||
| 35.34 | ||
| - | ||
| - | ||
| 69.11 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 2.15 | ||
| -5.48 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $305.43M | |
| $56.81M | ||
| $314.93M | ||
| $309.80M | ||
| $9.51M | ||
| $8.77M | ||
| Total Debt | $1.48M | |
| $737.00K | ||
| $1.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $78.31M | ||
| $82.22M | ||
| $839.00K | ||
| $0.00 | ||
| $839.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$64.83M | ||
| -$170.14M | ||
| $221.63M | ||
| Capex | $2.41M | |
| -$67.23M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | ||
| Citizens | → | |
| Truist Securities | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| JMP Securities | → | |
| JMP Securities | ||
| Jones Trading |
Analyst sentiment
Institutional ownership
Screeners with RAPP
Data Sources & References
- RAPP Official Website www.rapportrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2012593/000119312525268096/0001193125-25-268096-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2012593/000095017025036828/0000950170-25-036828-index.htm
- RAPP Profile on Yahoo Finance finance.yahoo.com/quote/RAPP
- RAPP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rapp
FAQ
What is the ticker symbol for Rapport Therapeutics, Inc.?
The ticker symbol for Rapport Therapeutics, Inc. is NASDAQ:RAPP
Does Rapport Therapeutics, Inc. pay dividends?
No, Rapport Therapeutics, Inc. does not pay dividends
What sector is Rapport Therapeutics, Inc. in?
Rapport Therapeutics, Inc. is in the Healthcare sector
What industry is Rapport Therapeutics, Inc. in?
Rapport Therapeutics, Inc. is in the Biotechnology industry
What country is Rapport Therapeutics, Inc. based in?
Rapport Therapeutics, Inc. is headquartered in United States
Is Rapport Therapeutics, Inc. in the S&P 500?
No, Rapport Therapeutics, Inc. is not included in the S&P 500 index
Is Rapport Therapeutics, Inc. in the NASDAQ 100?
No, Rapport Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Rapport Therapeutics, Inc. in the Dow Jones?
No, Rapport Therapeutics, Inc. is not included in the Dow Jones index
When was Rapport Therapeutics, Inc. last earnings report?
Rapport Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Rapport Therapeutics, Inc. report earnings?
The next expected earnings date for Rapport Therapeutics, Inc. is March 10, 2026